Year To Quarter End Consolidated Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7595304

Concept 2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
Year to quarter end consolidated statement of income
Statement of income
Net sales
44,000,000 JPY
15,269,000,000 JPY
13,646,000,000 JPY
-15,000,000 JPY
1,593,000,000 JPY
15,284,000,000 JPY
42,000,000 JPY
14,234,000,000 JPY
-12,000,000 JPY
12,840,000,000 JPY
1,351,000,000 JPY
14,221,000,000 JPY
Cost of sales
8,017,000,000 JPY
7,531,000,000 JPY
Gross profit (loss)
7,252,000,000 JPY
6,690,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
5,587,000,000 JPY
5,501,000,000 JPY
Operating profit (loss)
-18,000,000 JPY
1,664,000,000 JPY
1,728,000,000 JPY
-169,000,000 JPY
124,000,000 JPY
1,833,000,000 JPY
-2,000,000 JPY
1,348,000,000 JPY
-160,000,000 JPY
1,247,000,000 JPY
103,000,000 JPY
1,188,000,000 JPY
Non-operating income
Interest income
0 JPY
0 JPY
Dividend income
177,000,000 JPY
130,000,000 JPY
Share of profit of entities accounted for using equity method
JPY
64,000,000 JPY
Non-operating income
212,000,000 JPY
234,000,000 JPY
Non-operating expenses
Interest expenses
13,000,000 JPY
14,000,000 JPY
Non-operating expenses
71,000,000 JPY
92,000,000 JPY
Ordinary profit (loss)
1,805,000,000 JPY
1,329,000,000 JPY
Profit (loss) before income taxes
1,805,000,000 JPY
1,329,000,000 JPY
Income taxes - current
199,000,000 JPY
165,000,000 JPY
Income taxes - deferred
283,000,000 JPY
65,000,000 JPY
Income taxes
482,000,000 JPY
230,000,000 JPY
Profit (loss)
1,323,000,000 JPY
1,098,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
1,323,000,000 JPY
1,098,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
323,000,000 JPY
-35,000,000 JPY
Remeasurements of defined benefit plans, net of tax
6,000,000 JPY
7,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
139,000,000 JPY
-84,000,000 JPY
Other comprehensive income
469,000,000 JPY
-112,000,000 JPY
Comprehensive income
1,792,000,000 JPY
986,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
1,792,000,000 JPY
986,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.